Author

Abeer M. Shaaban

Queen Elizabeth Hospital BirminghamORCID 0000-0001-5784-8705Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Ahmed A. AhmediD· 1 shared Alastair Mark ThompsoniD· 1 shared Alexandra W. van den Belt‐DuseboutiD· 1 shared Amber Stiby· 1 shared Anargyros MegaliosiD· 1 shared Angelo FortunatoiD· 1 shared Anita E. GrigoriadisiD· 1 shared Anna Munsey· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Ahmed A. AhmedORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 15, 2025

MYBL2 maintains stemness and promotes theta-mediated end joining in triple negative breast cancer

Rachel Bayley, Anna Munsey, Suman Ahmed…·Paloma García

This study shows MYBL2 maintains stemness and promotes theta-mediated end joining in TNBC, and identifies Pol{theta}/ATR inhibition as a therapeutic strategy.

DOI 10.1101/2025.04.15.648875

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineNature GeneticsPeer-reviewedJun 1, 2022

Genomic profiling defines variable clonal relatedness between invasive breast cancer and primary ductal carcinoma in situ

Esther H. Lips, Tapsi Kumar, Anargyros Megalios…·Elinor J. Sawyer

The paper uses genomic profiling to show that some invasive breast cancers are clonally unrelated to their preceding DCIS, suggesting DCIS may act as both a precursor and independent risk factor.

98 citationstop 1%

humanwhole-exome sequencing

𝕏 PostBluesky